Onconetix board: Oakley and Meier resign; Dorf named Chairman; Epstein elected director

Onconetix, Inc.

Andrew Oakley and Thomas Meier resigned from the Board effective April 20, 2026, with no disagreement with management.
Sammy Dorf appointed Chairman of the Board effective April 23, 2026; receives $20,000/year paid quarterly.
Josh Epstein elected as a Class II director effective April 23, 2026; serves on Audit, Compensation, and chairs Nominating and Corp Gov Committee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.